Cargando…
The revised role of TGF-β in aortic aneurysms in Marfan syndrome
BACKGROUND: Recently, we demonstrated that losartan reduced the aortic root dilatation rate (AoDR) in adults with Marfan syndrome (MFS); however, responsiveness was diverse. The aim was to determine the role of transforming growth factor-β (TGF-β) as therapeutic biomarker for effectiveness of losart...
Autores principales: | Franken, R., Radonic, T., den Hartog, A. W., Groenink, M., Pals, G., van Eijk, M., Lutter, R., Mulder, B. J. M., Zwinderman, A. H., de Waard, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315797/ https://www.ncbi.nlm.nih.gov/pubmed/25342281 http://dx.doi.org/10.1007/s12471-014-0622-0 |
Ejemplares similares
-
No Beneficial Effect of General and Specific Anti-Inflammatory Therapies on Aortic Dilatation in Marfan Mice
por: Franken, Romy, et al.
Publicado: (2014) -
The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations
por: den Hartog, A. W., et al.
Publicado: (2016) -
Inflammation Aggravates Disease Severity in Marfan Syndrome Patients
por: Radonic, Teodora, et al.
Publicado: (2012) -
Aortic distensibility in Marfan syndrome: a potential predictor of aortic events?
por: van Andel, Mitzi M, et al.
Publicado: (2021) -
Abnormal aortic hemodynamics are associated with risk factors for aortic complications in patients with marfan syndrome
por: van Andel, Mitzi M., et al.
Publicado: (2022)